Hcw Biologics Inc (HCWB)

Apr 26, 2025

HCWB stock touches 52-week low at $6.99 amid sharp annual decline - Investing.com Australia

Apr 26, 2025

Apr 25, 2025

HCW Biologics (NASDAQ:HCWB) Trading 0.1% Higher – Here’s Why - Defense World

Apr 25, 2025

Apr 23, 2025

HCW Biologics faces lawsuit over construction contract breach - Investing.com Australia

Apr 23, 2025

Apr 22, 2025

HCW Biologics faces lawsuit over construction contract breach By Investing.com - Investing.com Canada

Apr 22, 2025

Apr 14, 2025

HCW Biologics enters key agreements; SEC non-review of filing By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

HCW Biologics enters key agreements; SEC non-review of filing - Investing.com

Apr 14, 2025

Apr 14, 2025

HCWB stock touches 52-week low at $8.04 amid market challenges By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

HCWB stock touches 52-week low at $8.04 amid market challenges - Investing.com Canada

Apr 14, 2025

Apr 07, 2025

HCWB stock touches 52-week low at $0.2 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

HCWB stock touches 52-week low at $0.2 amid sharp annual decline - Investing.com Australia

Apr 07, 2025

Apr 03, 2025

HCW Biologics Stock Set to Reverse Split on Friday, April 11th (NASDAQ:HCWB) - Defense World

Apr 03, 2025

Apr 02, 2025

HCW Biologics to Implement 1-for-40 Reverse Stock Split - MarketScreener

Apr 02, 2025

Apr 01, 2025

HCW Biologics approves reverse stock split to meet Nasdaq rules By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

HCW Biologics Announces 1-for-40 Reverse Stock Split - citybiz

Apr 01, 2025

Apr 01, 2025

HCW Biologics approves reverse stock split - Investing.com India

Apr 01, 2025

Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 01, 2025

Apr 01, 2025

HCW Biologics Announces Reverse Stock Split Approval - TipRanks

Apr 01, 2025

Apr 01, 2025

HCW Biologics approves reverse stock split to meet Nasdaq rules - Investing.com

Apr 01, 2025

Apr 01, 2025

HCW Biologics approves 1-for-40 reverse stock split - TipRanks

Apr 01, 2025

Apr 01, 2025

HCW Biologics Announces 1-For-40 Reverse Stock Split - MarketScreener

Apr 01, 2025

Apr 01, 2025

HCW Biologics approves reverse stock split By Investing.com - Investing.com Canada

Apr 01, 2025

Apr 01, 2025

Major Stock Restructuring: HCW Biologics Announces 40:1 Reverse Split for Nasdaq Compliance - Stock Titan

Apr 01, 2025

Apr 01, 2025

Warner Bros Discovery Stock (NASDAQ:WBD) Slides as Film Boss Replacements Considered - The Globe and Mail

Apr 01, 2025

Apr 01, 2025

How major US stock indexes fared Tuesday, 4/1/2025 - The Globe and Mail

Apr 01, 2025

Mar 30, 2025

HCW BIOLOGICS Earnings Preview: Recent $HCWB Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 30, 2025

Mar 29, 2025

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results - The Manila Times

Mar 29, 2025

Mar 28, 2025

HCW Biologics Inc. SEC 10-K Report - TradingView

Mar 28, 2025

Mar 28, 2025

HCW Biologics Secures FDA Green Light for Alopecia Treatment Despite $30M Annual Loss - Stock Titan

Mar 28, 2025

Mar 19, 2025

HCW Biologics amends agreement with WY Biotech amid delays - Investing.com

Mar 19, 2025

Mar 11, 2025

Stocks Attempt to Stabilize as Trump Set to Meet with Top US Executives - The Globe and Mail

Mar 11, 2025

Mar 07, 2025

HCW Biologics Granted Extension by the Nasdaq Hearings - GlobeNewswire

Mar 07, 2025

Mar 06, 2025

HCW Biologics Inc. Receives Extension from Nasdaq to Regain Compliance with Listing Rules - Nasdaq

Mar 06, 2025

Mar 06, 2025

Can HCW Biologics Meet Nasdaq's New June Deadline? Key Details Revealed - StockTitan

Mar 06, 2025

Feb 24, 2025

HCW Biologics Inc. announced that it expects to receive $20 million in funding -February 19, 2025 - Marketscreener.com

Feb 24, 2025

Feb 24, 2025

Zeta (ZETA) Q4 Earnings: What To Expect - The Globe and Mail

Feb 24, 2025

Feb 10, 2025

HCW Biologics Inc (HCWB) is looking forward to a strong quarter - SETE News

Feb 10, 2025

Feb 10, 2025

HCW Biologics Inc Inc. (HCWB) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Feb 10, 2025

Feb 10, 2025

Navigating the Volatility of HCW Biologics Inc’s (HCWB) Stock - The News Heater

Feb 10, 2025

Feb 06, 2025

Trading Day Review: HCW Biologics Inc (HCWB) Loses Momentum, Closing at 0.43 - The Dwinnex

Feb 06, 2025

Feb 05, 2025

The Business Case For Buying HCW Biologics Inc (NASDAQ: HCWB) Stock Now - Stocks Register

Feb 05, 2025

Feb 05, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Feb 05, 2025

Feb 04, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 04, 2025

Feb 04, 2025

HCW Biologics: Buy Rating Affirmed Amid IND Clearance and Strategic Advancements - TipRanks

Feb 04, 2025

Feb 04, 2025

HCW-9302 gains IND clearance for first-in-human study in alopecia areata - BioWorld Online

Feb 04, 2025

Feb 04, 2025

Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 04, 2025

Feb 03, 2025

HCW Biologics Inc Inc. (HCWB) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Feb 03, 2025

Feb 03, 2025

Penny Stocks To ResearchFebruary 03rd - MarketBeat

Feb 03, 2025

Feb 03, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 03, 2025

Feb 03, 2025

Pharma company granted FDA clearance for alopecia drug study - The Business Journals

Feb 03, 2025